difluoromethane,lithium
685831-11-2
|
Difluoromethane
75-10-5
|
difluoromethane,1,1,1,2,2-pentafluoroethane,1,1,1,2-tetrafluoroethane
158675-78-6
|
difluoromethane
2670-13-5
|
difluoromethane
2154-59-8
|
difluoromethane,hydrate
163227-90-5
|
(methylene-d2)iron(III)
93604-57-0
|
Allopurinol-d2
916979-34-5
|
Dopamine D2 receptor antagonist-1
1055411-77-2
|
4-ethoxy-N-(1-(2-methoxyethyl)-1,2,3,4-tetrahydroquinolin-7-yl)-3,5-dimethylbenzenesulfonamide
1170446-77-1
|
N-(5-benzoyl-4-phenylthiazol-2-yl)benzo[d][1,3]dioxole-5-carboxamide
922031-87-6
|
N-(1-(2-methoxyethyl)-1,2,3,4-tetrahydroquinolin-7-yl)-1-(m-tolyl)methanesulfonamide
1171510-38-5
|
N-(3-(benzo[d]thiazol-2-yl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)benzo[d][1,3]dioxole-5-carboxamide
922085-30-1
|
Ethyl 3-(benzo[d][1,3]dioxole-5-carboxamido)-5-phenylthiophene-2-carboxylate
922031-96-7
|
N-(3,3,5-trimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-8-yl)cyclohexanesulfonamide
922041-16-5
|
N-(3,3-dimethyl-4-oxo-5-propyl-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-8-yl)cyclohexanesulfonamide
921992-53-2
|
N-(3,3-dimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-8-yl)cyclohexanesulfonamide
922125-58-4
|
N-(5-isopentyl-3,3-dimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-8-yl)cyclohexanesulfonamide
922022-53-5
|
N-(3,3,5-trimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-7-yl)cyclohexanesulfonamide
922076-56-0
|
